Quantum Cyber N.V. Increase Decrease Through Exercise Of Options
Quantum Cyber N.V. (QUCY) reported Increase Decrease Through Exercise Of Options of $654.43 thousand for the 6-month period ending 2025-06-30, per its 6-K filed 2025-09-26.
Financial Statements › Notes
ifrs-full:IncreaseDecreaseThroughExerciseOfOptions · last filed 2025-09-26
- Quantum Cyber N.V. increase decrease through exercise of options for the quarter ending 2023-09-30 was $764.27K, a 70.44% decline year-over-year.
- Quantum Cyber N.V. increase decrease through exercise of options for the quarter ending 2023-06-30 was $764.01K, a 69.06% decline year-over-year.
- Quantum Cyber N.V. increase decrease through exercise of options for the quarter ending 2023-03-31 was $904.66K, a 62.69% decline year-over-year.
- Quantum Cyber N.V. increase decrease through exercise of options for the quarter ending 2022-09-30 was $2.59M.
| Period end | Increase Decrease Through Exercise Of Options 3 month | Increase Decrease Through Exercise Of Options 6 month | Increase Decrease Through Exercise Of Options 9 month | Increase Decrease Through Exercise Of Options 12 month |
|---|---|---|---|---|
| 2025-06-30 | $654.43K 6-K · filed 2025-09-26 | |||
| 2024-12-31 | $149.51K 20-F · filed 2025-03-31 | |||
| 2024-06-30 | $1.03M 6-K · filed 2025-09-26 | |||
| 2023-12-31 | $3.21M 20-F · filed 2025-03-31 | |||
| 2023-09-30 | $764.27K 6-K · filed 2023-11-16 | $1.53M derived: sum of 2 quarters · filed 2023-11-16 | $2.43M derived: sum of 3 quarters · filed 2023-11-16 | |
| 2023-06-30 | $764.01K 6-K · filed 2023-11-16 | $1.67M 6-K · filed 2024-10-18 | ||
| 2023-03-31 | $904.66K 6-K · filed 2023-11-16 | |||
| 2022-12-31 | $8.92M 20-F · filed 2025-03-31 | |||
| 2022-09-30 | $2.59M 6-K · filed 2023-11-16 | $5.05M derived: sum of 2 quarters · filed 2023-11-16 | $7.48M derived: sum of 3 quarters · filed 2023-11-16 | |
| 2022-06-30 | $2.47M 6-K · filed 2023-11-16 | $4.89M derived: sum of 2 quarters · filed 2023-11-16 | ||
| 2022-03-31 | $2.42M 6-K · filed 2023-11-16 | |||
| 2021-12-31 | $6.43M 20-F · filed 2024-04-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |